Bhonsle Sunil Insider Trades

Insider Trading History

Track insider trading activity for Bhonsle Sunil. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Titan Pharmaceuticals (de)
Titan Pharmaceuticals (de) TTNP
President And CEO
Holding Value $468k 200,000 shares
Last Trade
Apr 02, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$210M 200,000 shares
$1,050.00
$2.34
Titan Pharmaceuticals (de)
Titan Pharmaceuticals (de) TTNP
See Remarks
Holding Value $702k 300,000 shares
Last Trade
Sep 21, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$234M 300,000 shares
$780.12
$2.34
Titan Pharmaceuticals (de)
Titan Pharmaceuticals (de) TTNP
See Remarks
Holding Value $1.02M 435,578 shares
Last Trade
Sep 21, 2018 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$234M 300,000 shares
$780.12
$2.34
Tortoise Pipeline & Energy Fund
Tortoise Pipeline & Energy Fund TTP
See Remarks
Holding Value $20.7M 435,578 shares
Last Trade
Sep 21, 2018 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$21M 300,000 shares
$70.08
$47.61
Tortoise Pipeline & Energy Fund
Tortoise Pipeline & Energy Fund TTP
See Remarks
Holding Value $14.3M 300,000 shares
Last Trade
Sep 21, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$21M 300,000 shares
$70.08
$47.61
Titan Pharmaceuticals (de)
Titan Pharmaceuticals (de) TTNP
President And CEO
Holding Value $398k 170,000 shares
Last Trade
Mar 07, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$590M 170,000 shares
$3,468.96
$2.34
Titan Pharmaceuticals (de)
Titan Pharmaceuticals (de) TTNP
President And CEO
Holding Value $187k 80,000 shares
Last Trade
Feb 13, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.12B 80,000 shares
$14,040.00
$2.34
Titan Pharmaceuticals (de)
Titan Pharmaceuticals (de) TTNP
President And CEO
Holding Value $317k 135,578 shares
Last Trade
Jul 18, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$177M 10,000 shares
$17,748.00
$2.34
Titan Pharmaceuticals (de)
Titan Pharmaceuticals (de) TTNP
President And CEO
Holding Value $294k 125,578 shares
Last Trade
Feb 22, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$148M 11,763 shares
$12,600.00
$2.34
Titan Pharmaceuticals (de)
Titan Pharmaceuticals (de) TTNP
President And CEO
Holding Value $208k 89,100 shares
Last Trade
Feb 02, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.33B 89,100 shares
$14,940.00
$2.34
Titan Pharmaceuticals (de)
Titan Pharmaceuticals (de) TTNP
President And CEO
Holding Value $266k 113,815 shares
Last Trade
Jan 15, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$65.2M 5,841 shares
$11,160.00
$2.34
Titan Pharmaceuticals (de)
Titan Pharmaceuticals (de) TTNP
President And CEO
Holding Value $253k 107,974 shares
Last Trade
Jan 11, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$184M 17,000 shares
$10,800.00
$2.34
Titan Pharmaceuticals (de)
Titan Pharmaceuticals (de) TTNP
President And CEO
Holding Value $421k 180,000 shares
Last Trade
Dec 14, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.3B 180,000 shares
$18,360.00
$2.34
Titan Pharmaceuticals (de)
Titan Pharmaceuticals (de) TTNP
President And CEO
Holding Value $213k 90,900 shares
Last Trade
Dec 14, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.67B 90,900 shares
$18,360.00
$2.34
Titan Pharmaceuticals (de)
Titan Pharmaceuticals (de) TTNP
President
Holding Value $213k 90,974 shares
Last Trade
Oct 01, 2015 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$590k 200 shares
$2,952.00
$2.34
Titan Pharmaceuticals (de)
Titan Pharmaceuticals (de) TTNP
President
Holding Value $212k 90,774 shares
Last Trade
Sep 30, 2015 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.48M 500 shares
$2,952.00
$2.34
Titan Pharmaceuticals (de)
Titan Pharmaceuticals (de) TTNP
President
Holding Value $211k 90,274 shares
Last Trade
Sep 28, 2015 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.69M 910 shares
$2,952.00
$2.34
Titan Pharmaceuticals (de)
Titan Pharmaceuticals (de) TTNP
President
Holding Value $1.15M 491,500 shares
Last Trade
Sep 16, 2015 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$14.8M 5,000 shares
$2,952.00
$2.34
Titan Pharmaceuticals (de)
Titan Pharmaceuticals (de) TTNP
President
Holding Value $1.14M 486,500 shares
Last Trade
Sep 15, 2015 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$14.8M 5,000 shares
$2,952.00
$2.34
Titan Pharmaceuticals (de)
Titan Pharmaceuticals (de) TTNP
President
Holding Value $1.13M 481,500 shares
Last Trade
Aug 25, 2015 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$148M 50,000 shares
$2,952.00
$2.34

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up